|Bid||6.10 x 100|
|Ask||6.34 x 1600|
|Day's Range||6.13 - 6.63|
|52 Week Range||5.15 - 11.88|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 12, 2018 - Feb 16, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||11.25|
Ribbon Communications is one of many stocks the market is bullish on. Its expected double-digit top-line and bottom-line growth exceeds its peers, and its financially stable position lessens the chancesRead More...
The San Francisco-based company said it had a loss of 78 cents per share. The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research ...
NEW YORK, NY / ACCESSWIRE / February 12, 2018 / Invitae Corp. (NYSE: NVTA ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 12, 2018 at 4:30 PM Eastern Time. ...
Assessing Invitae Corporation’s (NYSE:NVTA) past track record of performance is a valuable exercise for investors. It enables us to reflect on whether the company has met or exceed expectations, whichRead More...
SAN FRANCISCO , Jan. 31, 2018 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced that Sean George , chief executive officer of ...
SAN FRANCISCO, Jan. 29, 2018 /PRNewswire/ -- Invitae Corporation (NVTA), one of the fastest growing genetic information companies, today announced that it will report its fourth quarter and year-end 2017 financial results on Monday, February 12, 2018 and will host a conference call and webcast that day at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and recent developments. The dial-in numbers for the conference call are (866) 393-4306 for domestic callers and (734) 385-2616 for international callers, and the reservation number for both is 1395729. The live webcast of the call may be accessed by visiting the investors section of the company's website at ir.invitae.com.
NEW YORK, Jan. 09, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Invitae ...
SAN FRANCISCO, Jan. 8, 2018 /PRNewswire/ -- Invitae Corporation (NVTA), one of the fastest growing genetic information companies, announced preliminary full-year 2017 results that demonstrate continued strong momentum, with volume and revenue more than doubling compared to 2016 results. 127% year-over-year growth in volume for the base business, excluding acquisitions, to more than 134,000 samples accessioned compared to approximately 59,000 in 2016. The results exceeded the high end of the company's previously increased projected range of 120,000-130,000 samples.
Most investors find it challenging to find companies with prospective double-digit growth rates that are also financially robust. These hidden gems also add meaningful upside to a portfolio, should theRead More...
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Invitae Corp. Here are 5 ETFs with the largest exposure to NVTA-US. Comparing the performance and risk of Invitae Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
SAN FRANCISCO, Dec. 20, 2017 /PRNewswire/ -- Invitae Corporation (NVTA), one of the fastest growing genetic information companies, today announced that Sean George, chief executive officer of Invitae, will present at the 36th Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2018 at 2:00 p.m. Pacific at The Westin St. Francis in San Francisco. Invitae Corporation's (NYSE: NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people.
-- Invitae to present findings at 2017 San Antonio Breast Cancer Symposium -- SAN ANTONIO , Dec. 5, 2017 /PRNewswire/ -- Research presented today by Invitae Corporation (NYSE: NVTA), one of the fastest ...
Categories: Yahoo FinanceGet free summary analysis Invitae Corp. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Invitae Corp. – Radius Health Inc, Fibrocell Science, Inc., Celldex Therapeutics, Inc. and HTG Molecular Diagnostics, Inc. (RDUS-US, FCSC-US, CLDX-US and HTGM-US) that have also reported for this period. ... Read more (Read more...)
SAN FRANCISCO, Nov. 15, 2017 /PRNewswire/ -- Invitae Corporation (NVTA), one of the fastest growing genetic information companies, today announced it has completed its acquisition of CombiMatrix, which specializes in providing genetic information for prenatal diagnosis, miscarriage analysis and diagnosis of pediatric developmental disorders, establishing Invitae as a new leader in family and reproductive genetic health services. "With the addition of CombiMatrix to Invitae, we have completed our entry into prenatal and perinatal genetics, currently the second-largest category of genetic testing services.
SAN FRANCISCO, Nov. 8, 2017 /PRNewswire/ -- Invitae Corporation (NVTA) one of the fastest growing genetic information companies, today issued a reminder to CombiMatrix Corporation Series F warrant holders regarding the previously announced offer to exchange (the "Exchange Offer") each outstanding Series F warrant (CUSIP No. 20009T147) (the "CombiMatrix Series F warrants") to acquire one share of common stock of CombiMatrix Corporation ("CombiMatrix") for 0.3056 of a share of common stock, par value $0.0001 per share, of Invitae (the "Invitae Common Stock"). All of the previously disclosed terms and conditions of the Exchange Offer remain unchanged.